Geron
GERN
#5741
Rank
NZ$2.00 B
Marketcap
NZ$3.14
Share price
-2.08%
Change (1 day)
-29.70%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -NZ$79.82 Million

According to Geron's latest financial reports the company's current earnings are NZ$0.18 Billion. In 2024 the company made an earning of -NZ$0.27 Billion, an increase over its 2023 earnings that were of -NZ$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$79.82 Million-69.4%
2024 -NZ$0.27 Billion-11.23%
2023 -NZ$0.3 Billion30.22%
2022 -NZ$0.23 Billion20.15%
2021 -NZ$0.19 Billion50.08%
2020 -NZ$0.13 Billion4.46%
2019 -NZ$0.12 Billion130.68%
2018 -NZ$51.93 Million8.84%
2017 -NZ$47.71 Million-3.08%
2016 -NZ$49.22 Million-22080.6%
2015 NZ$0.22 M-100.38%
2014 -NZ$59.47 Million-7.14%
2013 -NZ$64.04 Million
2011 -NZ$0.16 Billion19.04%
2010 -NZ$0.13 Billion8.45%
2009 -NZ$0.12 Billion-2.51%
2008 -NZ$0.13 Billion14.65%
2007 -NZ$0.11 Billion32.68%
2006 -NZ$79.14 Million25.59%
2005 -NZ$63.02 Million4.36%
2004 -NZ$60.39 Million19.73%
2003 -NZ$50.44 Million-15.46%
2002 -NZ$59.66 Million1.94%
2001 -NZ$58.52 Million33.59%
2000 -NZ$43.81 Million27.53%
1999 -NZ$34.35 Million63.13%
1998 -NZ$21.06 Million15.6%
1997 -NZ$18.22 Million-10.66%
1996 -NZ$20.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$16.51 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$2.65 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.12 Billion 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.20 B-368.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$15.86 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA